Home » Topics » Articles » Insight

Insight
RSS

Money Raised Year To Date

Sep. 15, 2003

Stock Winners and Losers For The Week

Sep. 15, 2003

Clinical Trial Update: August 2003

Sep. 15, 2003

Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: August 2003

Sep. 15, 2003

FDA Submissions, Approvals And Other Actions: August 2003

Sep. 15, 2003

BioWorld Stock Report For Public Biotechnology Companies

Sep. 15, 2003

Axokine's Promise Still Alive: Regeneron Restarting Program

Sep. 15, 2003

By Randy Osborne

Money Raised By Month

Sep. 8, 2003

Amgen Payout Ends Patent Fight; Genentech Adding Plant Capacity

Sep. 8, 2003

By Randy Osborne

Money Raised Year To Date

Sep. 8, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...